[go: up one dir, main page]

Harrison et al., 1996 - Google Patents

Plasma exchange with solvent/detergent‐treated plasma of resistant thrombotic thrombocytopenic purpura

Harrison et al., 1996

Document ID
3313286094726926599
Author
Harrison C
Lawrie A
Iqbal A
Hunter A
Machin S
Publication year
Publication venue
British journal of haematology

External Links

Snippet

A patient with unremitting thrombotic thrombocytopenic purpura (TTP), with circulating von Willebrand factor (VWF) multimers of unusually high molecular weight, and refractory to standard plasma exchange therapy, was treated with solvent detergent (S/D) plasma. The …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)

Similar Documents

Publication Publication Date Title
Harrison et al. Plasma exchange with solvent/detergent‐treated plasma of resistant thrombotic thrombocytopenic purpura
CA2051659C (en) Platelet membrane microparticles
US5300433A (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
Roseff et al. Guidelines for assessing appropriateness of pediatric transfusion
Manno et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children
Strauss et al. Pentastarch may cause fewer effects on coagulation than hetastarch
US4909940A (en) Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
Pamphilon Viral inactivation of fresh frozen plasma.
Rodeghiero et al. Replacement Therapy with Virus—Inactivated Plasma Concentrates in von Willebrand Disease
CN104231073B (en) Preparation method of human coagulation factor VIII
US5332578A (en) Platelet membrane microparticles
Tobe et al. Infusion of autologous platelet rich plasma does not reduce blood loss and product use after coronary artery bypass: a prospective, randomized, blinded study
Miura et al. Efficacy of several plasma components in a young boy with chronic thrombocytopenia and hemolytic anemia who responds repeatedly to normal plasma infusions
Politis et al. Quality and safety of fresh‐frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years’ experience
Williamson et al. Virally inactivated fresh frozen plasma
Federici et al. Von Willebrand's disease: clinical management
Spence Clinical use of plasma and plasma fractions
Rodriguez et al. Prophylactic cryoprecipitate in congenital afibrinogenemia
Tawes Jr et al. The plasma collection system: a new concept in autotransfusion
Niklasson et al. Thrombocytopenia and bleeding complications in severe cases of meningococcal infection treated with heparin, dextran 70 and chlorpromazine
O'Connell et al. Solvent–detergent plasma as replacement therapy in a pregnant patient with factor V deficiency
Furlan et al. Virus‐inactivated factor VIII concentrate prevents postoperative bleeding in a patient with von Willebrand's disease
Williamson ES04. 03 Correcting haemostasis.
Apelseth et al. Plasma and cryoprecipitate for transfusion
Womack Transfusion Medicine: Treating Thrombotic Thrombocytopenic Purpura With Plasma Exchange